Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells

Area of Science:

• Immunology
• Cell Biology
• Respiratory Medicine

Background:

• Asthma involves a Th2-immune response and compromised airway epithelial barrier function.
• Mechanisms linking Th2 cytokines to barrier dysfunction in asthma are not fully understood.

Purpose of the Study:

• To investigate the impact of Th2-type cytokines on airway epithelial barrier integrity.
• To elucidate the cellular and molecular mechanisms underlying cytokine-induced barrier dysfunction.

Main Methods:

• Human bronchial epithelial cells (16HBE14o-) were cultured and exposed to various cytokines (IL-4, IL-13, IL-25, IL-33, TSLP).
• Epithelial barrier function was assessed by measuring transepithelial electrical resistance (TEER) and dextran permeability.
• Apical junctional complex (AJC) structure and protein expression (occludin, ZO-1, β-catenin, E-cadherin) were analyzed via immunofluorescence.

Main Results:

• Exposure to IL-4 and IL-13 significantly decreased TEER and increased permeability in epithelial cells.
• IL-4 and IL-13 reduced the expression of membrane-associated AJC components.
• Innate type 2 cytokines (TSLP, IL-25, IL-33) did not significantly affect barrier function.
• IL-4-induced permeability was not mediated by PI3K signaling but was sensitive to JAK inhibition.

Conclusions:

• IL-4 and IL-13 disrupt airway epithelial barrier function, potentially contributing to allergic asthma.
• Th2 cytokine-induced epithelial barrier defects may play a role in airway inflammation.
• Targeting Th2 cytokine pathways could be a therapeutic strategy for asthma.